Cargando…

New developments of metformin in the clinical cancer area

Detalles Bibliográficos
Autor principal: Berstein, Lev M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305146/
https://www.ncbi.nlm.nih.gov/pubmed/30627318
http://dx.doi.org/10.18632/oncotarget.26418
_version_ 1783382499896852480
author Berstein, Lev M.
author_facet Berstein, Lev M.
author_sort Berstein, Lev M.
collection PubMed
description
format Online
Article
Text
id pubmed-6305146
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-63051462019-01-09 New developments of metformin in the clinical cancer area Berstein, Lev M. Oncotarget News Impact Journals LLC 2018-12-07 /pmc/articles/PMC6305146/ /pubmed/30627318 http://dx.doi.org/10.18632/oncotarget.26418 Text en Copyright: © 2018 Berstein http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (http://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle News
Berstein, Lev M.
New developments of metformin in the clinical cancer area
title New developments of metformin in the clinical cancer area
title_full New developments of metformin in the clinical cancer area
title_fullStr New developments of metformin in the clinical cancer area
title_full_unstemmed New developments of metformin in the clinical cancer area
title_short New developments of metformin in the clinical cancer area
title_sort new developments of metformin in the clinical cancer area
topic News
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305146/
https://www.ncbi.nlm.nih.gov/pubmed/30627318
http://dx.doi.org/10.18632/oncotarget.26418
work_keys_str_mv AT bersteinlevm newdevelopmentsofmetforminintheclinicalcancerarea